Loading…
Loading…
Tender Value
Refer Docs
Closing Date
3 Sept 2026, 11:00 am
Single Packet
Normal Tender
No
Itemwise/Consigneewise
Lowest to Highest
CONSIGNEE
Not Applicable
Expenditure
General
82
2 conditions · 1 needing a document upload
This item is reserved for procurement from Central Public Sector Enterprises (CPSEs) in terms of the Pharmaceuticals Preferential Purchase Policy (PPPP) issued by Government of India/Railway Board from time to time. Accordingly, offers received only from the following CPSEs shall be considered eligible for placement of order, subject to there being no restriction, ban, suspension, or blacklisting imposed on the concerned CPSE by any Government authority: Hindustan Antibiotics Ltd. Bengal Chemicals & Pharmaceuticals Ltd. Karnataka Antibiotics & Pharmaceuticals Ltd."
In keeping with the Public Procurement (Preference to Make in India) Order, 2017, as amended, and in terms of clause 2.4.2, 2.4.5 and 2.4.6 of Instructions to Tenderers Rev. 1.21 April 2024 (along with all its correction slips, if any), Public procurement of this item is restricted to Class - I and Class-II local suppliers only. Thus, only class-I and class-II local supplier as defined under the public procurement (Preference to Make in India) Order, 2017, as amended shall be eligible to bid in this tender. Offer from vendors who do not quality to be Class - I (Local Content: minimum 50%) or Class-II (Local Content: minimum 20% but less than 50%) local supplier, shall be summarily rejected and, therefore, such vendors should not participate in the tender. In case any vendor who does not qualify to be a Class - I or Class-II local supplier for the tendered item participates in the tender, such a bidder does so at its own risk and cost and Railways shall not be liable for any loss or damage caused to the bidder on this account. NOTE-1: - As per Public Procurement (Preference to Make in India) Order, 2017, procurements where the estimated value to be procured is less than Rs 5 lakhs shall be exempt from this Order. NOTE-2: - Items which are exempted under GTE list are also exempted from above criteria.
17 conditions
NOT APPLICABLE
In terms of clause as per Para 2.4.3 of Instruction to Tenderers regarding restrictions on procurement form a bidder of a country which shares a land border with India. I, hereby confirm that I have read the clause regarding restrictions on procurement form a bidder of a country which shares a land border with India and I certify that I am not from such a country.
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
4 locations across Delhi, Punjab, Uttar Pradesh · 52,436 Numbers total
AMI No- 9.146/2026-27 Tab./Cap. Norfloxacin 400mg and Tinidazole 600mg
82260320~NR
82260320
Limited - Indigenous
Goods
Lucknow, Uttar Pradesh
₹0
Exempted
21 Aug 2026
21 Aug 2026
1 item · 52,436 Numbers total
AMI No- 9.146/2026-27 Tab./Cap. Norfloxacin 400mg and Tinidazole 600mg [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitt ed: Max 8 lacs ] ]
| Delivery Location | State | Quantity |
|---|---|---|
| NR Central Hospital, NR | Delhi | 15000.00 Numbers |
| NR Divisional Hospital Delhi, NR | Delhi | 6000.00 Numbers |
| NR Divisional Hospital Firozpu, NR | Punjab | 29436.00 Numbers |
| NR Divisional Hospital Lucknow, NR | Uttar Pradesh | 2000.00 Numbers |
| Total | 52,436 Numbers | |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
HTML
nit.pdf
NIT
5615616.pdf
ATTACHMENT
5615615.pdf
ATTACHMENT
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].